Effect of Exenatide on Brain Glucose Uptake in Relations to Pancreatic, Adipose Tissue, and Hepatic Function

Trial Profile

Effect of Exenatide on Brain Glucose Uptake in Relations to Pancreatic, Adipose Tissue, and Hepatic Function

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 May 2017

At a glance

  • Drugs Exenatide (Primary)
  • Indications Glucose intolerance; Obesity; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Sep 2016 Results assessing effect on hepatic and adipose tissue insulin resistance published in the Hepatology
    • 17 Sep 2014 Status changed from recruiting to completed, as reported by results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
    • 17 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top